尚榮醫療(002551.SZ):2023年度預虧1.0億元-1.5億元
格隆匯1月26日丨尚榮醫療(002551.SZ)公佈2023年度業績預吿,報吿期歸屬於上市公司股東的淨利潤虧損10000萬元—15000萬元,比上年同期增長67.54%—51.31%;扣除非經常性損益後的淨利潤虧損10517.49萬元—15517.49萬元,比上年同期增長67.63%—52.25%;基本每股收益虧損0.118元/股—0.178元/股。
報吿期內,公司控股子公司合肥普爾德醫療用品有限公司(以下簡稱“普爾德醫療”)和普爾德控股有限公司(以下簡稱“普爾德控股”)的主要產品為一次性醫用防護產品和一次性醫用耗材產品。因國內市場競爭加劇導致醫用防護產品的國內產能大幅提升,產品利潤率持續下降,致使本報吿期普爾德醫療和普爾德控股的銷售和利潤大幅下降。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.